language English
Article 2022 · 3 atıf

Theophylline attenuates bleomycin-induced oxidative stress in rats: The role of IL-6, NF-KB, and antioxidant enzymes

Ekin, Suat, Yildirim, Serkan, Akkoyun, Mahire Bayramoglu, Gok, Hasya Nazli, Arihan, Okan, Oto, Gokhan, Akkoyun, Turan, Basbugan, Yildiray, Aslan, Sinem

Özet

The purpose of this study was to evaluate the antifibrotic and antioxidant roles of theophylline (Theo), a bioactive compound, in bleomycin (BLM)-induced pulmonary fibrosis in Wistar albino rats. Assigned into 4 groups were 32 Wistar albino rats, comprising the control group (administered 0.9% isotonic saline), BLM group (treated with BLM at a dose of 2.5 mg/kg), BLM+Theo group (treated with Theo at a dose of 75 mg/kg + BLM at a dose of 2.5 mg/kg), and Theo group (treated with Theo at a dose of 75 mg/kg). In the BLM group, a significant decrease was observed in the catalase and glutathione peroxidase enzyme activities, and reduced glutathione (GSH) (p < 0.05, p < 0.05, p < 0.001, respectively), while the malondialdehyde (MDA) levels (p < 0.001) were significantly elevated when compared to the control group. However, the MDA levels in the BLM+Theo group were also significantly higher than in the control group (p < 0.01). Similarly, the GSH levels were significantly higher in the BLM+Theo group than in the BLM group (p < 0.05). The results indicated that Theo reduced the BLM-induced activation of nuclear factor-kappaB (NF-kappa B) and decreased interleukin-6 (IL-6) levels, together with significant amelioration of the immunohistochemical and histopathological architecture in the lung tissues. It was concluded that the administration of Theo had a positive effect on the GSH level, and activation of NF-kappa B and IL-6 expression, which were significant proinflammatory markers in the BLM-treated rats.

Anahtar Kelimeler
Theophylline Bleomycin IL-6 NF-?B Antioxidant enzymes INDUCED PULMONARY-FIBROSIS INDUCED LUNG FIBROSIS KAPPA-B ACID DRUGS ALPHA CELLS ASSAY
WoS Kategorileri
Pharmacology & Pharmacy
Sürdürülebilir Kalkınma Amaçları
Künye
Dergi
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES
Yıl
2022
Cilt
58
ISSN
1984-8250
eISSN
2175-9790
DOI
10.1590/s2175-97902022e20827
WoS UID
WOS:000904499400001
Yayını aç (DOI)